| 中文名 | PF-CBP1盐酸盐 |
|---|---|
| 英文名 | PF-CBP1 hydrochloride |
| 中文别名 |
PF-CBP1盐酸
4-(2-(5-(3,5-二甲基异恶唑-4-基)-2-(4-丙氧基苯乙基)-1H-苯并[D]咪唑-1-基)乙基)吗啉盐酸盐 |
| 英文别名 |
PF-CBP1 hydrochloride(b)
PF-CBP1 (hydrochloride) 5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[2-(morpholin-4-yl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-1,3-benzodiazole 5-(3,5-Dimethyl-4-isoxazolyl)-1-[2-(4-morpholinyl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-benzimidazole Hydrochloride 4-[2-[5-(3,5-dimethylisoxazol-4-yl)-2-[2-(4-propoxyphenyl)ethyl]benzimidazol-1-yl]ethyl]morpholine pkinson's disease,HATs,cortical,inflammatory,HAT,Histone Acetyltransferase,PF CBP1 hydrochloride,inhibit,RGS4,ilsy,igenetic Reader Domain,PF-CBP1,PFCBP1 hydrochloride,Inhibitor,neurological disorder,PF-CBP-1 hydrochloride,neuron 4-(2-(5-(3,5-Dimethylisoxazol-4-yl)-2-(4-propoxyphenethyl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholine hydrochloride PF-CBP1 hydrochloride, 10 mM in DMSO |
| 描述 | PF-CBP1盐酸盐是一种CREB结合蛋白溴区的高度选择性抑制剂。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C29H36N4O3·HCl |
|---|---|
| 分子量 | 525.08 |
| 外观性状 | 粉末 |
| 储存条件 | -20℃ |